Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario De Matteis

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Drugs - Real World Outcomes|March 1, 2020
Correction to: Once‑Monthly Long‑Acting Injectable Aripiprazole for the Treatment of Patients with Schizophrenia and Co‑occurring Substance Use Disorders: A Multicentre, Observational StudyNestor Szerman, Ignacio Basurte-Villamor, Pablo Vega, et al.
Drugs - Real World Outcomes|February 7, 2020
Once-Monthly Long-Acting Injectable Aripiprazole for the Treatment of Patients with Schizophrenia and Co-occurring Substance Use Disorders: A Multicentre, Observational StudyNestor Szerman, Ignacio Basurte-Villamor, Pablo Vega, et al.
The European Journal of Neuroscience|August 24, 2017
Mismatch negativity to pitch pattern deviants in schizophreniaSarah M Haigh, Mario De Matteis, Brian A Coffman, et al.
Pediatrics|October 6, 2019
Dietary Interventions for Autism Spectrum Disorder: A Meta-analysisDavid Fraguas, Covadonga M Díaz-Caneja, Laura Pina-Camacho, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 21, 2023
The polygenic basis of relapse after a first episode of schizophreniaÀlex-González Segura, Llucia Prohens, Patricia Gassó, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Drugs - Real World Outcomes|March 1, 2020
Correction to: Once‑Monthly Long‑Acting Injectable Aripiprazole for the Treatment of Patients with Schizophrenia and Co‑occurring Substance Use Disorders: A Multicentre, Observational StudyNestor Szerman, Ignacio Basurte-Villamor, Pablo Vega, et al.
Drugs - Real World Outcomes|February 7, 2020
Once-Monthly Long-Acting Injectable Aripiprazole for the Treatment of Patients with Schizophrenia and Co-occurring Substance Use Disorders: A Multicentre, Observational StudyNestor Szerman, Ignacio Basurte-Villamor, Pablo Vega, et al.
The European Journal of Neuroscience|August 24, 2017
Mismatch negativity to pitch pattern deviants in schizophreniaSarah M Haigh, Mario De Matteis, Brian A Coffman, et al.
Pediatrics|October 6, 2019
Dietary Interventions for Autism Spectrum Disorder: A Meta-analysisDavid Fraguas, Covadonga M Díaz-Caneja, Laura Pina-Camacho, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 21, 2023
The polygenic basis of relapse after a first episode of schizophreniaÀlex-González Segura, Llucia Prohens, Patricia Gassó, et al.
Pageof 1